Log In
CQMS
Make a Donation
Log In
Donate
TROG 2026 ASM: Early Bird Registration now open
Support our Km's for Cancer Research challenge today
$1.9 million grant sees TROG bring international trial to Australia
Apply now for Attendance Grants for our 2026 ASM
Submit your trial idea for our Concept Development Workshop before 2 November.

TROG 99.04/ALLG LY02 – Osteolymphoma – OL

Completed
Lymphoma

A Prospective, Non-Randomised Study of Chemotherapy and Radiotherapy for Osteolymphoma (OL)

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Prev Post

TROG 99.05 – Lung Tumour Volume

Next Post

TROG 99.02 – Anal Canal

Related Post

23 October, 2025

TROG collaboration sees international skin cancer trial open in Australia

LATEST NEWS: 23 October 2025 TROG Cancer Research has

21 October, 2025

Grandad’s mission to walk 10,000 steps a day to support cancer research

LATEST NEWS: 21 October 2025 Walking at least 10,000